A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors...

  • Main
  • 2017 / 10
  • A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors...
Targeted Oncology 2017 / 10

A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer

Wainberg, Zev A., Alsina, Maria, Soares, Heloisa P., Braña, Irene, Britten, Carolyn D., Del Conte, Gianluca, Ezeh, Patrick, Houk, Brett, Kern, Kenneth A., Leong, Stephen, Pathan, Nuzhat, Pierce, Krist
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Targeted Oncology
DOI:
10.1007/s11523-017-0530-5
Date:
October, 2017
File:
PDF, 938 KB
english, 2017
Conversion to is in progress
Conversion to is failed